Plans & access
Investors pay for cleared time and priority — never for a listing wall. Companies pay with evidence. No fee ever rides on a closed deal, and the market holds no stake in anything it grades.
Sandbox billing connected — checkout is live against Stripe test mode; amounts remain placeholder pending the willingness-to-pay work.
For investors — per cell, per access level
ObserverFreethe open door: market pulse, happenings, teasers — see that the market moves
- Market pulse per cell
- Happenings feed
- Pre-consent teasers (blurred counts)
Participant≈ €900 / cell / year (demo)priced like the memberships investors already pay (angel-network band), not like a data terminal
- The full graded card in your cells
- The company read through the shared lens
- Request meetings (double opt-in)
- Screening at scale, apples to apples
AnchorEnterprise (demo)for funds with a standing mandate — priority is worth more than access
- 48–72h first look before the cell opens
- Standing-mandate priority
- Launch & Demo-Day presence
For companies — evidence in, never equity to the referee
Free DiagnosisConnect evidence, get the grade + your private gap report — free, always
Market trialList with your grade — first two months on the market included (demo rule)
Platform subscription = the listing rightYour company platform subscription carries the listing; deeper evidence lifts the grade, the credits and the reach
The market never takes shares in a listed company and never charges a fee on a closed round — the grade is worthless the day the referee holds a stake in the game.
Market intelligence
≈ €3,000 / year (demo)Volume per cell, velocity, valuation bands — the market's source of record, sold as data, never as advice.